Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is. A new study published today shows how an experimental new test called ‘ExoGrail‘ has the potential to revolutionise how patients with suspected prostate cancer are risk-assessed prior to an invasive biopsy. […]
Read More… from Urine test could reduce invasive cancer biopsies
Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth: Prostate cancer is one of the most commonly diagnosed forms of cancer in men and affects around 5,600 men in Austria each year. Hormone therapy is one of the core treatment strategies, but it is only effective for a certain period of time. It has been known […]
Read More… from Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the finding of the long-term analyses of an international phase 3 clinical trial, recently published in the leading journal “European Urology”. The study showed that overall survival was 2 – 3 times higher than in the […]
Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer Research, London, has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate cancer. The decision puts the NHS in England and Wales out […]
Read More… from Prostate cancer treatment abiraterone not available
New screening test improves detection of Prostate Cancer using circulating tumor cells and prostate-specific markers. Melbourne-based National Institute of Medicine is the first to pioneer a ground-breaking test to detect Prostate Cancer earlier. Seeking study participants to undertake second phase of research New Australian research has shown that a ground-breaking test can improve the early […]
Feasibility of genetic screening for prostate cancer Genetic ‘barcoding’ in GP surgeries picks out men at increased risk for follow-up checks Pilot study shows population screening is feasible for improving disease detection Larger-scale study to begin which could prove effectiveness of a prostate cancer screening programme Genetic screening for prostate cancer in […]
Read More… from Feasibility of genetic screening for prostate cancer
New data will offer a unique insight into whether prostate MRI could be the test that we are looking for to preferentially detect those cancers which will benefit from treatment, whilst minimising over-detection and overtreatment which can only cause harm. The first attempt at prostate cancer screening assessed nearly 6000 men with annual digital rectal […]
Read More… from The Continued Evolution of Prostate Cancer Screening
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal. The PROfound trial compared the genetically targeted cancer drug olaparib – already licensed for women with breast and ovarian cancer who have BRCA […]
Read More… from Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer
Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with fewer side effects. A new study, carried out at six hospitals across the UK, tracked 625 men with prostate cancer who received a type of treatment called high-intensity focused ultrasound (HIFU). The research, published in the […]
Read More… from HIFU is effective against prostate cancer with fewer side effects
Just days after revealing he underwent surgery for prostate cancer, 60-year-old actor and TV presenter Stephen Fry has returned to work. Fry announced that he had his prostate and 11 lymph nodes removed in January after being diagnosed with cancer he describes as an “aggressive little bugger.” Following this he stepped down as presenter of […]
Read More… from Stephen Fry returns to work after prostate cancer surgery